Reverse Transcriptase Inhibitors
Showing 1 - 25 of 6,843
Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)
Active, not recruiting
- Chronic Hepatitis B
- NrtIs
- +2 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 20, 2023
HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease
Active, not recruiting
- HIV-1 Infection
- Doravirine, Tenofovir, Lamivudine
- +4 more
- (no location specified)
Sep 2, 2022
Aicardi Goutières Syndrome Trial in Philadelphia (Tenofovir (TDF) and Emtricitabine (FTC), Placebo)
Not yet recruiting
- Aicardi Goutières Syndrome
- Tenofovir (TDF) and Emtricitabine (FTC)
- Placebo
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Feb 8, 2022
Psoriasis Trial in Montpellier, Nîmes (Generic antiretroviral)
Recruiting
- Psoriasis
- Generic antiretroviral
-
Montpellier, France
- +1 more
Jun 18, 2021
Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)
Recruiting
- Chronic Hepatitis B
- VRON-0200-AdC6
- VRON-0200-AdC7
-
Hong Kong, Hong Kong
- +1 more
Oct 6, 2023
HIV-1 Infection Trial in France (Samplings)
Recruiting
- HIV-1 Infection
- Samplings
-
Clamart, France
- +6 more
Jan 4, 2022
HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)
Recruiting
- HIV-1-infection
- Multi-Antiviral Resistance
- REGISTER CREATION
-
Milan, MI, ItalyOspedale San Raffaele
Dec 22, 2021
Chronic HBV Infection Trial in China (Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003,
Recruiting
- Chronic HBV Infection
- Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
- +2 more
-
Beijing, Beijing, China
- +7 more
Feb 23, 2023
Maternal-fetal Infection Transmission Trial in France (darunavir monotherapy)
Completed
- Maternal-fetal Infection Transmission
- darunavir monotherapy
-
Argenteuil, France
- +22 more
Aug 5, 2021
HIV Trial in Worldwide (Darunavir (DRV) 800 milligram (MG) Oral Tablet, Ritonavir 100 MG Oral Tablet, N(t)RTIs)
Recruiting
- HIV Infections
- Darunavir (DRV) 800 milligram (MG) Oral Tablet
- +6 more
-
Chennai, India
- +6 more
Aug 30, 2021
HIV Trial in Worldwide (GSK3640254, ABC/3TC, FTC/TAF)
Active, not recruiting
- HIV Infections
- GSK3640254
- +4 more
-
Los Angeles, California
- +65 more
Jul 18, 2022
HIV, Bariatric Surgery Candidate Trial (bariatric surgery)
Not yet recruiting
- HIV Infections
- Bariatric Surgery Candidate
- bariatric surgery
- (no location specified)
Sep 9, 2022
HIV, Tuberculosis Trial in Bangkok (LPV/r)
Completed
- HIV Infections
- Tuberculosis
-
Bangkok, ThailandHIV-NAT Thai Red Cross AIDS Research Center
Jul 15, 2020
Aicardi-Goutières Syndrome Trial in Edinburgh (Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine
Recruiting
- Aicardi-Goutières Syndrome
- Abacavir (ABC)
- +2 more
-
Edinburgh, United KingdomYanick Crow
Aug 26, 2022
HIV-1-infection Trial in Johannesburg (Doravirine/Lamivudine/Tenofovir)
Recruiting
- HIV-1-infection
-
Johannesburg, Gauteng, South Africa
- +2 more
Jun 6, 2022
Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.
Completed
- Integrase Inhibitors, HIV; HIV PROTEASE INHIB
-
Barcelona, SpainHospital Clinic
Aug 29, 2019
HIV-1-infection, Solid Organ Transplant Trial in Barcelona (Lamivudine 300 MG, Abacavir 600 MG, Dolutegravir 50 mg)
Unknown status
- HIV-1-infection
- Solid Organ Transplant
- Lamivudine 300 MG
- +4 more
-
Barcelona, SpainHospital Clínico y provincial de Barcelona
Feb 4, 2020
Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA
Recruiting
- HIV-1-infection
- Genotypic Resistance Test
-
Paris, FranceARVD
Jul 21, 2021
Pumilio1 Expression, Sickle Cell Anemia, ß-thalassemia
Not yet recruiting
- Sickle Cell Disease, Beta Thalassemia Intermedia
- RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
- (no location specified)
May 30, 2023
Aicardi-Goutières Syndrome (AGS) Trial in Paris (Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir)
Completed
- Aicardi-Goutières Syndrome (AGS)
- Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir
-
Paris, FranceHôpital Necker - Enfants Malades
Mar 14, 2019